Combined antiretroviral therapy has improved quality and life expectancy of people living with human immunodeficiency virus (HIV). However, this therapy increases oxidative stress (OS), which in turn causes alterations in lipid and carbon metabolism, kidney disease, liver cirrhosis, and increased risk of cardiovascular disease. The Klotho gene has been implicated in cardiovascular risk increase. Klotho protein expression at X level decreases the risk of heart disease. HIV-positive people usually present low plasma levels of Klotho; thus, contributing to some extent to an increase in cardiovascular risk for these types of patients, mostly by favoring atherosclerosis. Therefore, our aim is to provide an overview of the effect of OS on Klotho protein and its consequent cardiometabolic alterations in HIV-positive patients on antiretroviral therapy.
Get full access to this article
View all access options for this article.
References
1.
AndrukhovaO., SmorodchenkoA., EgerbacherM., StreicherC., ZeitzU., GoetzR., et al. (2014). FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J, 33, 229–246.
2.
ArkingD.E., AtzmonG., ArkingA., BarzilaiN., and DietzH.C. (2005). Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res, 96, 412–418.
3.
ArkingD.E., KrebsovaA., MacekM., Sr., MacekM.Jr., ArkingA., MianI.S., et al. (2002). Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A, 99, 856–861.
4.
AugustoO., and MiyamotoS. (2011). Oxygen Radicals and Related Species. In: Principles of Free Radical Biomedicine, K. Pantopoulos, H.M. Schipper, eds. Nova Science Publishers, Inc.
5.
BhattacharyyaA., ChattopadhyayR., MitraS., and CroweS.E. (2014). Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev, 94, 329–354.
6.
CorsettiG., PasiniE., ScarabelliT.M., RomanoC., AgrawalP.R., Chen-ScarabelliC., et al. (2016). Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular disease. J Geriatr Cardiol, 13, 701–711.
7.
CouretJ., and ChangT.L. (2016). Reactive oxygen species in HIV infection. EC Microbiol 3,597.
8.
DaltonG.D., XieJ., AnS.-W., and HuangC.-L. (2017). New insights into the mechanism of action of soluble klotho. Front Endocrinol 8,323.
9.
Donate-CorreaJ., Martín-NúñezE., Martínez-SanzR., Muros-de-FuentesM., Mora-FernándezC., Pérez-DelgadoN., and Navarro-GonzálezJ.F. (2016). Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease. J Cell Mol Med, 20, 128–133.
10.
D'AscenzoF., CerratoE., Biondi-ZoccaiG., MorettiC., OmedeP., SciutoF., et al. (2012). Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J, 33, 875–880.
11.
D'AscenzoF., QuadriG., CerratoE., CalcagnoA., OmedèP., MarraW.G., et al. (2015). A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. J Cardiovasc Med, 16, 839–843.
12.
DrogeW., EckH.P., and MihmS. (1994). Oxidant-antioxidant status in human immunodeficiency virus infection. Methods Enzymol, 233, 594–601.
13.
ElbimC., PilletS., PrevostM., PreiraA., GirardP., RogineN., et al. (1999). Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. J Virol, 73, 4561–4566.
14.
EliasA., NelsonB., OputiriD., and GeoffreyO.-B.P. (2013). Antiretroviral toxicity and oxidative stress. Am J Pharmacol Toxicol 8,187.
15.
Fon TacerK., BookoutA.L., DingX., KurosuH., JohnG.B., WangL., et al. (2010). Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol, 24, 2050–2064.
16.
Gallego-EscuredoJ.M., DomingoP., del Mar GutiérrezM., MateoM.G., CabezaM.C., FontanetA., et al. (2012). Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients. JAIDS J Acquir Immune Defic Syndr, 61, 527–534.
17.
GiliS., Grosso MarraW., D'AscenzoF., LonniE., CalcagnoA., CannilloM., et al. (2016). Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. Eur Heart J, 37, 3600–3609.
18.
GutowskiM., and KowalczykS. (2013). A study of free radical chemistry: their role and pathophysiological significance. Acta Biochim Pol, 60, 1–16.
19.
Hans-PeterE., GmünderH., HartmannM., PetzoldtD., DanielV., and DrögeW. (1989). Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler, 370, 101–108.
20.
HaoQ., DingX., GaoL., YangM., and DongB. (2016). G-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old. Age (Dordr) 38,7.
21.
HulganT., DonahueJ.P., HawkinsC., UnutmazD., D'AquilaR.T., RaffantiS., et al. (2003a). Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy. J Acquir Immune Defic Syndr (1999), 34, 119–126.
22.
HulganT., MorrowJ., D'AquilaR.T., RaffantiS., MorganM., RebeiroP., and HaasD.W. (2003b). Oxidant stress is increased during treatment of human immunodeficiency virus infection. Clin Infect Dis, 37, 1711–1717.
23.
InagakiT., ChoiM., MoschettaA., PengL., CumminsC.L., McDonaldJ.G., et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab, 2, 217–225.
24.
Ito, S., Fujimori, T., Hayashizaki, Y., and Nabeshima, Y.-i. (2002). Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. Biochim Biophys Acta 1576, 341–345.
25.
ItoS., KinoshitaS., ShiraishiN., NakagawaS., SekineS., FujimoriT., et al. (2000). Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family protein. Mech Dev, 98, 115–119.
26.
IvanovA.V., BartoschB., and IsaguliantsM.G. (2017). Oxidative stress in infection and consequent disease. Oxid Med Cell Longev 2017,3496043.
27.
Jacob VictorinoV., MorimotoH., Maria Vissoci ReicheE., and PanisC. (2015). Redox-driven events in the human immunodeficiency virus type 1 (HIV-1) infection and their clinical implications. Curr HIV Res, 13, 143–150.
28.
JeongS.J., SongJ.E., KimS.B., KimH.W., KuN.S., HanS.H., et al. (2013). Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy. AIDS Res Hum Retroviruses, 29, 1575–1581.
29.
KearnsA., GordonJ., BurdoT.H., and QinX. (2017). HIV-1–associated atherosclerosis: unraveling the missing link. J Am Coll Cardiol, 69, 3084–3098.
30.
KelesN., CaliskanM., DoganB., KelesN.N., KalcikM., AksuF., et al. (2015). Low serum level of Klotho is an early predictor of atherosclerosis. Tohoku J Exp Med, 237, 17–23.
31.
KelesidisT., JacksonN., McComseyG.A., WangX., ElashoffD., DubeM.P., et al. (2016). Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS, 30, 2625–2633.
32.
KenyonC. (2005). The plasticity of aging: insights from long-lived mutants. Cell, 120, 449–460.
33.
KharitonenkovA. (2009). FGFs and metabolism. Curr Opin Pharmacol, 9, 805–810.
34.
KokkinakiM., Abu-AsabM., GunawardenaN., AhernG., JavidniaM., YoungJ., et al. (2013). Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. J Neurosci, 33, 16346–16359.
Kuro-oM. (2011). Klotho and the aging process. Korean J Intern Med 26,113.
37.
Kuro-oM., MatsumuraY., AizawaH., KawaguchiH., SugaT., UtsugiT., et al. (1997). Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 39,45.
38.
KurosuH., OgawaY., MiyoshiM., YamamotoM., NandiA., RosenblattK.P., et al. (2006). Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem, 281, 6120–6123.
39.
LimK., LuT.-S., MolostvovG., LeeC., LamF., ZehnderD., and HsiaoL.-L. (2012). Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation, 125, 2243–2255.
40.
LusisA.J., MarR., and PajukantaP. (2004). Genetics of atherosclerosis. Annu Rev Genomics Hum Genet, 5, 189–218.
41.
MajumdarV., NagarajaD., and ChristopherR. (2010). Association of the functional KL-VS variant of Klotho gene with early-onset ischemic stroke. Biochem Biophys Res Commun, 403, 412–416.
42.
MargaritisM. (2019). Endothelial dysfunction in HIV infection: experimental and clinical evidence on the role of oxidative stress. Ann Res Hospitals, 3, 1–11.
43.
MasiáM., PadillaS., FernándezM., RodríguezC., MorenoA., OteoJ.A., et al. (2016). Oxidative stress predicts all-cause mortality in HIV-infected patients. PLoS One 11,e0153456.
44.
Matsumura, Y., Aizawa, H., Shiraki-Iida, T., Nagai, R., Kuro-o, M., and Nabeshima, Y.-i. (1998). Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein. Biochem Biophys Res Commun 242, 626–630.
45.
MenckeR., and HillebrandsJ.L. (2017). The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology. Ageing Res Rev, 35, 124–146.
MoureR., DomingoP., VillarroyaJ., GasaL., Gallego-EscuredoJ.M., Quesada-LópezT., et al. (2018). Reciprocal effects of antiretroviral drugs used to treat HIV infection on the fibroblast growth factor 21/β-Klotho system. Antimicrob Agents Chemother, 62, e00029–18.
48.
Navarro-GonzálezJ.F., Donate-CorreaJ., de FuentesM.M., Pérez-HernándezH., Martínez-SanzR., and Mora-FernándezC. (2014). Reduced Klotho is associated with the presence and severity of coronary artery disease. Heart, 100, 34–40.
49.
Nsonwu-AnyanwuA.C., IghodaloE.V., KingD., ElochukwuA.C., JeremiahS., SolomonO.T., et al. (2017). Biomarkers of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. Reactive Oxygen Species, 3, 197–207.
50.
NzietchuengR., El ShamiehS., BenachourH., LabatC., HerbethB., NdiayeN.C., et al. (2011). Klotho KL-VS genotype is involved in blood pressure regulation. Clin Chim Acta, 412, 1773–1777.
51.
OgawaY., KurosuH., YamamotoM., NandiA., RosenblattK.P., GoetzR., et al. (2007). βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci U S A, 104, 7432–7437.
52.
Okechukwu, I.B. (2015). Oxidative Stress, Redox Regulation and Elite Controllers of HIV Infection: Towards a Functional Cure. Trends in Basic and Therapeutic Options in HIV Infection–Towards a Functional Cure. InTechOpen, DOI: 10.5772/60806.
53.
Papadopulos-EleopulosE., Hedland-ThomasB., CauserD., TurnerV., PapadimitriouJ., DrögeW., et al. (1991). Changes in thiols and glutamate as consequence of simian immunodeficiency virus infection. Lancet, 338, 1013–1014.
54.
PreedyV.R., WatsonR.R. (2017). HIV/AIDS: Oxidative stress and dietary antioxidants. Elsevier, p. 267.
55.
PriceT.O., ErcalN., NakaokeR., and BanksW.A. (2005). HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res, 1045, 57–63.
56.
RepettoM., ReidesC., CarreteroM.L.G., CostaM., GriembergG., and LlesuyS. (1996). Oxidative stress in blood of HIV infected patients. Acta Clin Chim, 255, 107–117.
57.
ReyskensK.M., and EssopM.F. (2014). HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin–proteasome system. Biochim Biophys Acta, 1842, 256–268.
58.
RichterB., HallerJ., HaffnerD., and Leifheit-NestlerM. (2016). Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells. Pflügers Arch, 468, 1621–1635.
59.
SchieberM., and ChandelN.S. (2014). ROS function in redox signaling and oxidative stress. Curr Biol, 24, R453–R462.
60.
SchwarzK.B. (1996). Oxidative stress during viral infection: a review. Free Radic Biol Med, 21, 641–649.
61.
SembaR.D., CappolaA.R., SunK., BandinelliS., DalalM., CrastoC., et al. (2011). Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc, 59, 1596–1601.
62.
SharmaA., SlaughterA., JenaN., FengL., KesslJ.J., FadelH.J., et al. (2014). A new class of multimerization selective inhibitors of HIV-1 integrase. PLoS Pathog 10,e1004171.
63.
SharmaB. (2014). Oxidative stress in HIV patients receiving antiretroviral therapy. Curr HIV Res, 12, 13–21.
64.
ShresthaS., IrvinM.R., GrunfeldC., and ArnettD.K. (2014). HIV, inflammation, and calcium in atherosclerosis. Arterioscler Thromb Vasc Biol, 34, 244–250.
65.
SmithC.J., RyomL., WeberR., MorlatP., PradierC., ReissP., et al. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration. Lancet, 384, 241–248.
66.
SopjaniM., RinnerthalerM., AlmilajiA., AhmetiS., and Dermaku-SopjaniM. (2014). Regulation of cellular transport by klotho protein. Curr Protein Peptide Sci, 15, 828–835.
67.
SS/CENSIDA. (2019). Directorate of Operational Research, based on the HIV Epidemiological Surveillance System and AIDS [translated from Spanish]. Secretaria de Salud; Centro Nacional para la Prevención y Control del VIH/sida (Censida).
68.
StaalF., RoedererM., and HerzenbergL.A. (1990). Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A, 87, 9943–9947.
69.
StaalF.J., RoedererM., IsraelskiD.M., BubpJ., MoleL.A., McShaneD., et al. (1992). Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses, 8, 305–311.
70.
SundaramM., SaghayamS., PriyaB., VenkateshK.K., BalakrishnanP., ShankarE.M., et al. (2008). Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India. Int J Infect Dis, 12, e61–e66.
71.
TetoG., KanmogneG.D., TorimiroJ.N., AlemnjiG., NguemaimF.N., TakouD., et al. (2013). Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon. PLoS One 8,e65126.
72.
Therond, P., Bonnefont-Rousselot, D., Davit-Spraul, A., Conti, M., and A. Legrand. (2000). Biomarkers of oxidative stress: An analytical approach. Curr Opin Clin Nutr Metab 3, 373–384.
73.
VachiatA., McCutcheonK., TsabedzeN., ZachariahD., and MangaP. (2017). HIV and ischemic heart disease. J Am Coll Cardiol, 69, 73–82.
74.
WilliamsA.A., SitoleL.J., and MeyerD. (2017). HIV/HAART-associated oxidative stress is detectable by metabonomics. Mol Biosyst, 13, 2202–2217.
75.
YamamotoM., ClarkJ.D., PastorJ.V., GurnaniP., NandiA., KurosuH., et al. (2005). Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem, 280, 38029–38034.
